| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| AULT MILTON C III | Director | 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS | /s/ Milton C. Ault, III | 2025-10-03 | 0001212502 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALZN | Common Stock | Conversion of derivative security | $232K | +100K | +316.2% | $2.32 | 132K | Oct 1, 2025 | By Ault Lending, LLC | F1, F2 |
| transaction | ALZN | Common Stock | Sale | -$86.4K | -36.8K | -27.94% | $2.35 | 94.8K | Oct 1, 2025 | By Ault Lending, LLC | F2, F3 |
| transaction | ALZN | Common Stock | Sale | -$49.5K | -20.7K | -21.81% | $2.39 | 74.2K | Oct 2, 2025 | By Ault Lending, LLC | F2 |
| transaction | ALZN | Common Stock | Sale | -$161K | -65.9K | -88.86% | $2.44 | 8.26K | Oct 3, 2025 | By Ault Lending, LLC | F2, F4 |
| holding | ALZN | Common Stock | 1.84K | Oct 1, 2025 | Direct | ||||||
| holding | ALZN | Common Stock | 11.1K | Oct 1, 2025 | By Ault Life Sciences, Inc. | F5 | |||||
| holding | ALZN | Common Stock | 61 | Oct 1, 2025 | By Ault Life Sciences Fund, LLC | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALZN | Series B Convertible Preferred Stock | Conversion of derivative security | -$232K | -232 | -27.64% | $1,000.00 | 607 | Oct 1, 2025 | Common Stock | 100K | $2.32 | By Ault Lending, LLC | F2, F7, F8 |
| holding | ALZN | Common Stock Purchase Warrants | 13.6K | Oct 1, 2025 | Common Stock | 13.6K | $108.00 | By Ault Lending, LLC | F2 | |||||
| holding | ALZN | Common Stock Purchase Warrants | 8.67K | Oct 1, 2025 | Common Stock | 8.67K | $108.00 | By Ault Lending, LLC | F2 | |||||
| holding | ALZN | Common Stock Purchase Warrants | 1.11K | Oct 1, 2025 | Common Stock | 1.11K | $108.00 | By Ault Lending, LLC | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred"). |
| F2 | Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |
| F3 | The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.3487. The range of sales prices on the transaction date was $2.317 to $2.4038 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. |
| F4 | The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.4413. The range of sales prices on the transaction date was $2.4409 to $2.467 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. |
| F5 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. |
| F6 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. |
| F7 | The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock. |
| F8 | The shares of Series B Preferred have no expiration date. |